drugset / Trial / NCT01673529

Investigation of Topical SB705498 on Healthy Volunteers

NCT01673529

Phase 1 Completed 16 enrolled GlaxoSmithKline
RandomizedSingle-groupQuadruple-blindTreatment

Summary

A two part, randomized, double-blind, placebo controlled study to investigate the effects of topical doses of SB705498 in healthy volunteers.

Timeline

Start
2012-07-17
Primary completion
2012-10-04
Completion
2012-10-04

Drugs

EvaluationDrugModalityDoseRoute
Subject SB-705498 Small molecule 1 % Topical
Subject SB-705498 Small molecule 3 % Topical
Subject SB-705498 Small molecule 5 % Topical

Indications